Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001840936 | SCV002099749 | uncertain significance | not provided | 2022-02-25 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001840936 | SCV002959986 | benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002543268 | SCV003608128 | uncertain significance | Inborn genetic diseases | 2022-02-03 | criteria provided, single submitter | clinical testing | The c.7382C>T (p.P2461L) alteration is located in exon 33 (coding exon 33) of the ADGRV1 gene. This alteration results from a C to T substitution at nucleotide position 7382, causing the proline (P) at amino acid position 2461 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |